ORIFARM GROUP A/S: Financial statements 2018
CVR: 27347282
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ORIFARM GROUP A/S (CVR 27347282) has filed annual accounts for 2018. In 2018, the company reported revenue of EUR 10,016,000 and a net result of EUR 26,454,000 compared with EUR 21,881,000 the year before. That is an increase of 16.3% compared with the year before. The profit margin was 264.1%. Equity in the 2018 report amounted to EUR 135,963,000. The solvency ratio was 68.8%. The company had 1,036 employees in the financial year.
- Revenue
- EUR 10,016,000
- Gross Profit
- EUR 10,146,000
- Profit/Loss
- EUR 26,454,000
- Equity
- EUR 135,963,000
- Total Assets
- EUR 197,698,000
- Employees
- 1,036
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 10 mio. EUR | 10.1 mio. EUR | 26.5 mio. EUR | 136 mio. EUR | 1036 |
| 2017 | 8.6 mio. EUR | 8.8 mio. EUR | 21.9 mio. EUR | 117 mio. EUR | 797 |
| 2016 | 8.8 mio. EUR | 8.8 mio. EUR | 10.2 mio. EUR | 98.5 mio. EUR | 960 |
| 2015 | 9.8 mio. EUR | 9.8 mio. EUR | 9.1 mio. EUR | 90.3 mio. EUR | - |
| 2014 | 11.4 mio. EUR | 11.5 mio. EUR | 6.2 mio. EUR | 60.4 mio. EUR | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of December 20, 2018, Hans Carl Bøgh-Sørensen has joined the board of directors of ORIFARM GROUP A/S.
As of December 20, 2018, Peter Arend William Burema has left the board of directors of ORIFARM GROUP A/S.
As of December 20, 2018, Erik Sandberg is registered as adm. dir. of ORIFARM GROUP A/S.
As of December 20, 2018, Hans Carl Bøgh-Sørensen has stepped down as adm. dir. of ORIFARM GROUP A/S.
As of December 19, 2018, Erik Sandberg has stepped down as director of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2017. Revenue came to DKK 8,611,000, and the net result was DKK 21,881,000.
As of May 15, 2018, Eva Berner is registered as director of ORIFARM GROUP A/S.
As of May 15, 2018, Ulrik Ernst Rasmussen has stepped down as director of ORIFARM GROUP A/S.
As of February 21, 2018, Karen Lykke Sørensen has joined the board of directors of ORIFARM GROUP A/S.
About ORIFARM GROUP A/S
ORIFARM GROUP A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The company was previously named CAREFARM A/S. The management consists of Mads Fink Eriksen and Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Ole Michael Friis, Adeel Ahmad and Bettina Britt Juel Hansen. The company is owned by Orifarm Holding A/S. The company has 211 employees (2026). In 2025, the company reported a gross profit of EUR 1,478,000 and a net result of EUR 51,761,000 compared with EUR 3,260,000 the year before. Equity in the 2025 report amounted to EUR 413,677,000.